PHILADELPHIA — A federal court in Pennsylvania granted final approval of two class action antitrust settlements totaling about $70 million, resolving claims that Glenmark Pharmaceuticals, Greenstone and Pfizer participated in a conspiracy to inflate generic drug prices.Read the ruling here.Subscribe to our free newslettersOur weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.Additional Reads
Generic drug price inflation settlements
Full Article
Original Source
Read the full article at Courthousenews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.